(Press-News.org) WHAT:
A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver. This is the first clinical trial of semaglutide for MASLD in people with HIV. The research was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and conducted in the United States and Brazil by ACTG, a global clinical trials network focused on HIV and other infectious diseases. ACTG is funded by NIAID and collaborating NIH institutes. McGovern Medical School at UTHealth Houston also contributed funding for this study.
Previously known as nonalcoholic fatty liver disease, MASLD is characterized by the accumulation of excess fat in the liver that is not caused by alcohol consumption or viral hepatitis. Over time, fat deposits may cause inflammation and cellular damage, and can result in cardiovascular and liver disease. MASLD also is associated with obesity, type 2 diabetes, and other metabolic disorders. It is the most common cause of chronic liver disease in the United States, and a leading reason for liver transplantation. An estimated 30-40% of people with HIV experience MASLD, slightly higher than the average among people without HIV. Semaglutide is an antidiabetic medication approved for use for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management.
The Phase 2b pilot study enrolled people with HIV and MASLD aged 18 years and older whose viral load—the amount of HIV in the blood—was suppressed to undetectable levels by antiretroviral therapy (ART). Participants were diverse with respect to ethnicity, race, gender, and age. Of the 49 participants included in the analysis, 40 (82%) were taking ART regimens containing an integrase strand transfer inhibitor, which is a class of antiretroviral drugs shown to be highly effective at suppressing HIV but associated with weight gain in some people.
Participants self-injected semaglutide on a weekly basis at increasing doses until they reached a 1 milligram dose at week four and participated in frequent safety monitoring visits. At 24 weeks, the study team assessed changes in participants’ liver fat content using a type of MRI specifically designed to measure the amount of fat in the liver. Participants experienced an average 31% reduction in liver fat, with 29% of participants experiencing a complete resolution of MASLD, meaning their liver fat decreased to 5% or less of overall liver content. They also experienced weight loss, reduced fasting blood glucose (the amount of sugar in the blood) and reduced fasting triglycerides (a type of fat in the blood), consistent with effects observed in studies of semaglutide in people without HIV.
A separate analysis showed the volume of psoas muscle—a large muscle connecting the torso to the lower body—also decreased with no significant change in physical function. Semaglutide was generally well tolerated with an adverse event profile similar to that observed in people without HIV. The most common adverse events were gastrointestinal and included nausea, diarrhea, vomiting, and abdominal pain. Two participants experienced more significant adverse events possibly related to semaglutide but were able to continue in the study. All participants completed the full 24 weeks of therapy at the originally prescribed dose.
These findings suggest that semaglutide is a safe and effective therapy for MASLD in people with HIV. The study may help inform healthcare decisions by people in consultation with their providers, as part of an approach to healthier aging with HIV over the life span. According to the investigators, additional research is underway to understand whether people with HIV experience any unique immunologic or inflammatory pathway changes while taking semaglutide therapy.
PRESENTATIONS:
Lake et al. Semaglutide Reduces Metabolic-Associated Steatotic Liver Disease in People With HIV: The SLIM LIVER Study. Conference on Retroviruses and Opportunistic Infections in Denver, Colorado. Tuesday, March 5, 2024.
Ditzenberger et al. Effects of Semaglutide on Muscle Structure and Function in the SLIM Liver Study. Conference on Retroviruses and Opportunistic Infections in Denver, Colorado. Monday, March 4, 2024.
WHO:
Sarah Read, M.D., deputy director of NIAID’s Division of AIDS, is available to discuss this research.
CONTACT:
To schedule interviews, please contact the NIAID News & Science Writing Branch, (301) 402-1663, NIAIDNews@niaid.nih.gov.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH...Turning Discovery Into Health®
END
The Lancet: Experts warn about the overmedicalisation of menopause and call for a new approach to how society views menopause and supports women as they age
Menopause is a life stage for half the world’s population and is generally depicted in a negative way. However, women’s experiences of menopause are unique and vary hugely.
The Lancet 2024 Series on menopause argues that an over-simplified narrative of menopause as a health problem to be solved by replacing hormones is not based on evidence and deflects attention from the need for substantial societal shifts in how menopause, and midlife/older women in general, are viewed and treated around the world.
The ...
A new review paper from authors at Brigham and Women’s Hospital and collaborators concludes that menopause does not uniformly elevate the risk of depression and other mental health conditions.
Menopause has long been thought to cause psychological distress, but a new review suggests that this is not always the case. The review, written by experts from Brigham Women’s Hospital, a founding member of the Mass General Brigham healthcare system, and international collaborators, is the third in a series of menopause-themed papers published in The ...
1. A research team consisting of NIMS and the Tokyo Institute of Technology has identified materials capable of catalyzing the conversion of ortho-hydrogen to para-hydrogen. These catalysts should be essential to the spread of mass-transportation/storage of liquid hydrogen.
2. Hydrogen is becoming widely accepted as an alternative energy source to fossil fuels. Its liquefaction (at temperatures below -253°C under pressures higher than one atmosphere) can dramatically reduce its volume, making it suitable for transportation and storage. Hydrogen molecules (H2)—each composed of two hydrogen atoms—exist in two isomeric forms: ortho- and para-H2. Under normal conditions, ...
Retirement is a major transition that can have a significant impact on a person’s life.
For some, retirement evokes thoughts of slowing down, relaxing, and enjoying more of what life has to offer. For others, ending a regular work schedule can create stress and uncertainties about being able to pay necessary bills and maintain adequate medical care.
A new study by researchers at the Yale School of Public Health examines how retirement affects mental health and related inpatient mental health care among female workers in China, ...
FOR IMMEDIATE RELEASE
Media Contact: LEVI GADYE (628) 399-1046
Levi.Gadye@ucsf.edu
Subscribe to UCSF News
A Smart Molecule Beats the Mutation Behind Most Pancreatic Cancer
Scientists discover a new way to disarm a deadly protein that also appears in cancers of the lung, breast and colon.
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
The new molecule permanently modifies a wily cancer-causing ...
In a new Nature Communications study, Columbia Engineering researchers report that they have built highly conductive, tunable single-molecule devices in which the molecule is attached to leads by using direct metal-metal contacts. Their novel approach uses light to control the electronic properties of the devices and opens the door to broader use of metal-metal contacts that could facilitate electron transport across the single-molecule device.
The challenge
As devices continue to shrink, their electronic ...
Chestnut Hill, Mass. (03/05/2024) – Boston College researchers used a mild charge of electricity to precisely modify proteins, a new tool that can be used to develop novel biotherapeutics and protein-based research tools, the team reported recently in the journal Nature Chemistry.
The team, led by BC professors of chemistry Abhishek Chatterjee and Eranthie Weerapana, developed and optimized a novel electrochemical protein labeling reaction called "eCLIC", that enables precise modification of site-specifically incorporated 5-hydroxytryptophan (5HTP) residues on many different proteins including full-length therapeutic antibodies.
“We used this strategy to generate ...
There are plenty of reasons to worry about the quality of contemporary Canadian journalism, beyond shrinking newsrooms and attention spans.
Once considered a vital pillar of a healthy democracy, the country’s biggest newspapers have been embracing the type of content critics refer to as “infotainment,” which uses entertainment-style methods to communicate politically relevant information.
In a new paper published in the Canadian Journal of Political Science, PhD candidate Robert Marinov examines, measures and evaluates the scope and nature ...
AMES, Iowa – At a Biotechnology Council event a few years ago, Nicole Valenzuela’s ears perked up when she heard what a group of researchers in Iowa State University’s College of Veterinary Medicine had in the works: a method for creating a lab-grown, simplified mimic of dog intestines.
“I told them, ‘Oh! I want to do that but with turtles. Is it doable?” said Nicole Valenzuela, professor of ecology, evolution and organismal biology at Iowa State.
It is indeed doable, new research from a team led by Valenzuela shows. The three-dimensional clusters ...
Parkinson’s disease patients who experience freezing of gait (a sudden inability to initiate or continue movement, often resulting in a fall) wake up several times during the night, feel sleepy during the day, and have REM sleep behavior disorder. Rapid eye movement (REM) sleep plays a role in the maintenance of many cognitive processes.
These are key findings of a study supported by FAPESP and conducted by researchers at São Paulo State University (UNESP) in Brazil and Grenoble Alps University (UGA) in France. An article on the study is published in ...
